Celularity Inc.CELUNASDAQ
Loading
CELU Revenue Growth (YoY Quarterly)•-43.16%
Stock Alarm Pro
Growth Metrics
Latest: Q3 2025vs Q2 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-43.16%
+9.5pp
-39.66%
+55.4pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+19.89%
+10.0pp
+19.89%
+10.0pp
+0.00%
+0.0pp
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +145.54% | +49.70% | -22.17% | -52.64% | -43.16% |
| Gross Profit Growth | +2841.85% | +331.04% | -39.64% | -95.05% | -39.66% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | -169.70% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | -239.24% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | -220.70% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | -220.70% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +16.70% | +15.35% | +9.75% | +9.93% | +19.89% |
| Weighted Average Shares Diluted Growth | +16.70% | +15.35% | +9.75% | +9.93% | +19.89% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +41.77% | +11.87% | -5.51% | -17.22% | -23.55% |
| Inventory Growth | -19.68% | -5.98% | +67.44% | +51.29% | -35.33% |
| Asset Growth | -18.04% | -7.79% | -10.39% | -11.23% | -11.33% |
| Book Value per Share Growth | -51.05% | -81.30% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +13.07% | +5.23% | +5.62% | +122.01% | -3.33% |
| R&D Expense Growth | -24.45% | -96.46% | -36.20% | -11.79% | +17.45% |
| SG&A Expenses Growth | +17.70% | +22.88% | +1.67% | -20.58% | -26.43% |
1 / 4